Used in research for treating neurodegenerative diseases, particularly Huntington’s disease. Acts as a selective antagonist for the sigma-1 receptor, helping modulate cellular stress responses and improve neuronal function in preclinical models. Investigated for potential neuroprotective effects and ability to reduce disease-related symptoms in animal studies. Currently not approved for clinical use, but serves as a tool compound in neuroscience research.